BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 38244055)

  • 1. Macrophage profiling in atherosclerosis: understanding the unstable plaque.
    Gianopoulos I; Daskalopoulou SS
    Basic Res Cardiol; 2024 Feb; 119(1):35-56. PubMed ID: 38244055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage phenotypes in atherosclerosis.
    Colin S; Chinetti-Gbaguidi G; Staels B
    Immunol Rev; 2014 Nov; 262(1):153-66. PubMed ID: 25319333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological relevance of macrophage subsets in atherogenesis.
    Liberale L; Dallegri F; Montecucco F; Carbone F
    Thromb Haemost; 2017 Jan; 117(1):7-18. PubMed ID: 27683760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in transcriptome of macrophages in atherosclerosis.
    Chistiakov DA; Bobryshev YV; Orekhov AN
    J Cell Mol Med; 2015 Jun; 19(6):1163-73. PubMed ID: 25973901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Macrophage activation in atherosclerosis. Message 1: Activation of macrophages normally and in atherosclerotic lesions].
    Nikiforov NG; Kornienko VY; Karagodin VP; Orekhov AN
    Patol Fiziol Eksp Ter; 2015; (3):128-31. PubMed ID: 26852607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation.
    Li H; Cao Z; Wang L; Liu C; Lin H; Tang Y; Yao P
    Front Immunol; 2022; 13():843712. PubMed ID: 35432323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of macrophage phenotypes and responses in atherosclerosis.
    Jinnouchi H; Guo L; Sakamoto A; Torii S; Sato Y; Cornelissen A; Kuntz S; Paek KH; Fernandez R; Fuller D; Gadhoke N; Surve D; Romero M; Kolodgie FD; Virmani R; Finn AV
    Cell Mol Life Sci; 2020 May; 77(10):1919-1932. PubMed ID: 31720740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage heterogeneity in atherosclerosis: A matter of context.
    Wieland EB; Kempen LJ; Donners MM; Biessen EA; Goossens P
    Eur J Immunol; 2024 Jan; 54(1):e2350464. PubMed ID: 37943053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage subsets in atherosclerosis as defined by single-cell technologies.
    Willemsen L; de Winther MP
    J Pathol; 2020 Apr; 250(5):705-714. PubMed ID: 32003464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy.
    Momtazi-Borojeni AA; Abdollahi E; Nikfar B; Chaichian S; Ekhlasi-Hundrieser M
    Heart Fail Rev; 2019 May; 24(3):399-409. PubMed ID: 30673930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Cell Transcriptomics Reveals Crucial Cell Subsets and Functional Heterogeneity Associated With Carotid Atherosclerosis and Cerebrovascular Events.
    Tan J; Liang Y; Yang Z; He Q; Tong J; Deng Y; Guo W; Liang K; Tang J; Shi W; Yu B
    Arterioscler Thromb Vasc Biol; 2023 Dec; 43(12):2312-2332. PubMed ID: 37881939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage subsets in atherosclerosis.
    Chinetti-Gbaguidi G; Colin S; Staels B
    Nat Rev Cardiol; 2015 Jan; 12(1):10-7. PubMed ID: 25367649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-gated sodium channel inhibitor reduces atherosclerosis by modulating monocyte/macrophage subsets and suppressing macrophage proliferation.
    Sun H; Jiang J; Gong L; Li X; Yang Y; Luo Y; Guo Z; Lu R; Li H; Li J; Zhao J; Yang N; Li Y
    Biomed Pharmacother; 2019 Dec; 120():109352. PubMed ID: 31586905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage phenotypes and their modulation in atherosclerosis.
    De Paoli F; Staels B; Chinetti-Gbaguidi G
    Circ J; 2014; 78(8):1775-81. PubMed ID: 24998279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes.
    Chistiakov DA; Bobryshev YV; Nikiforov NG; Elizova NV; Sobenin IA; Orekhov AN
    Int J Cardiol; 2015 Apr; 184():436-445. PubMed ID: 25755062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe
    Leipner J; Dederichs TS; von Ehr A; Rauterberg S; Ehlert C; Merz J; Dufner B; Hoppe N; Krebs K; Heidt T; von Zur Muehlen C; Stachon P; Ley K; Wolf D; Zirlik A; Bode C; Hilgendorf I; Härdtner C
    Mol Metab; 2021 Nov; 53():101250. PubMed ID: 33991749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage polarization and metabolism in atherosclerosis.
    Hou P; Fang J; Liu Z; Shi Y; Agostini M; Bernassola F; Bove P; Candi E; Rovella V; Sica G; Sun Q; Wang Y; Scimeca M; Federici M; Mauriello A; Melino G
    Cell Death Dis; 2023 Oct; 14(10):691. PubMed ID: 37863894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage Plasticity and Atherosclerosis Therapy.
    Lin P; Ji HH; Li YJ; Guo SD
    Front Mol Biosci; 2021; 8():679797. PubMed ID: 34026849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression.
    Lin JD; Nishi H; Poles J; Niu X; Mccauley C; Rahman K; Brown EJ; Yeung ST; Vozhilla N; Weinstock A; Ramsey SA; Fisher EA; Loke P
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque.
    Kowara M; Cudnoch-Jedrzejewska A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.